Due to high demands for affordable care, the hurdle to gain reimbursement for innovative products are much higher today.
Today's market demands that products demonstrate COMPARATIVE CLINICAL EFFECTIVENESS AND ECONOMIC VALUE or risk being non-reimbursable.
Gone are the days where small and mid-sized companies with products in early development can postpone pricing and reimbursement considerations just prior to launch or larger companies can expect premium pricing with minimal clinical benefits.
To be successful in today’s market, products must be able to demonstrate:
Relevant comparator and end points that are meaningful to payers
Value propositions that resonate with key stakeholders
Value Genome consultants are here to partner and assist your team innovator to actualize the clinical and economic value of your assets. Our goal is to help innovators to optimize the financial return whether it’s licensing, acquisition or brining a life changing product to market.